Loading…

Prognostic factors in patients who received end-of-life chemotherapy for advanced cancer

Background Clinical efficacy of aggressive end-of-life (EOL) chemotherapy remains unclear. Method Medical records of patients with advanced cancer between August 2011 and August 2016 were retrospectively analyzed. The primary endpoint was to identify prognostic factors at the last administration of...

Full description

Saved in:
Bibliographic Details
Published in:International journal of clinical oncology 2019-04, Vol.24 (4), p.454-459
Main Authors: Hiramoto, Shuji, Tamaki, Tomoko, Nagashima, Kengo, Hori, Tetsuo, Kikuchi, Ayako, Yoshioka, Akira, Inoue, Akira
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background Clinical efficacy of aggressive end-of-life (EOL) chemotherapy remains unclear. Method Medical records of patients with advanced cancer between August 2011 and August 2016 were retrospectively analyzed. The primary endpoint was to identify prognostic factors at the last administration of chemotherapy. The secondary endpoint was to analyze the relationship between EOL symptoms and EOL treatment details. Results Among 300 evaluated patients, the number of patients who died within 14 and 30 days from the last administration of chemotherapy were 16 (5.3%) and 50 (16.7%), respectively. Multivariate analysis revealed that ECOG-PS (OR 3.698, p  
ISSN:1341-9625
1437-7772
DOI:10.1007/s10147-018-1363-7